Capricor Therapeutics (CAPR) Earnings Date, Estimates & Call Transcripts → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free CAPR Stock Alerts $5.38 -0.04 (-0.74%) (As of 01:48 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13After Market ClosesConfirmedActual EPS (Feb. 29) -$0.02 Beat By $0.21 Consensus EPS (Feb. 29) -$0.23 Get Capricor Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for CAPR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCAPR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CAPR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Unstoppable ProsperityRSVP: Charles Payne’s Cash Flow WorkshopAre you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies.Register For Free Now! Capricor Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.11)($0.11)($0.11)Q2 20241($0.32)($0.32)($0.32)Q3 20241($0.31)($0.31)($0.31)Q4 20241($0.17)($0.17)($0.17)FY 20244($0.91)($0.91)($0.91)CAPR Earnings Date and InformationCapricor Therapeutics last issued its quarterly earnings data on February 29th, 2024. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.21. The business earned $12.09 million during the quarter, compared to the consensus estimate of $5.80 million. Capricor Therapeutics has generated ($0.87) earnings per share over the last year (($0.87) diluted earnings per share). Earnings for Capricor Therapeutics are expected to grow in the coming year, from ($0.83) to $0.12 per share. Capricor Therapeutics has confirmed that its next quarterly earnings report will be published on Monday, May 13th, 2024. Capricor Therapeutics will be holding an earnings conference call on Monday, May 13th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Capricor Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Confirmed)------- 2/29/2024Q4 2023($0.23)($0.02)+$0.21($0.02)$5.80 million$12.09 million11/14/2023Q3 2023($0.27)($0.25)+$0.02($0.25)$3.33 million$6.19 million8/7/2023Q2 2023($0.34)($0.29)+$0.05($0.29)-$3.92 million5/11/2023Q1 2023($0.32)($0.31)+$0.01($0.31)$1.00 million$2.99 million3/15/2023Q4 2022-($0.31)($0.31)($0.31)$0.01 million$0.96 million11/10/2022Q3 2022($0.28)($0.26)+$0.02($0.26)$0.42 million$1.59 million Get the Latest News and Ratings for CAPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capricor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/10/2022Q2 2022($0.25)($0.29)($0.04)($0.29)-- 5/10/2022Q1 2022-($0.32)($0.32)($0.32)--3/10/2022Q4 2021($0.19)($0.26)($0.07)($0.26)-- 11/8/2021Q3 2021($0.22)($0.17)+$0.05($0.17)-- 8/12/2021Q2 2021($0.23)($0.21)+$0.02($0.21)$0.21 million$0.20 million 5/13/2021Q1 2021-($0.23)($0.23)($0.23)-$0.04 million Capricor Therapeutics Earnings - Frequently Asked Questions When is Capricor Therapeutics's earnings date? Capricor Therapeutics has confirmed that its next quarterly earnings data will be published on Monday, May 13th, 2024. Learn more on CAPR's earnings history. Did Capricor Therapeutics beat their earnings estimates last quarter? In the previous quarter, Capricor Therapeutics (NASDAQ:CAPR) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.23) by $0.21. Learn more on analysts' earnings estimate vs. CAPR's actual earnings. How much revenue does Capricor Therapeutics generate each year? Capricor Therapeutics (NASDAQ:CAPR) has a recorded annual revenue of $25.18 million. How much profit does Capricor Therapeutics generate each year? Capricor Therapeutics (NASDAQ:CAPR) has a recorded net income of -$22.29 million. CAPR has generated -$0.87 earnings per share over the last four quarters. What is Capricor Therapeutics's EPS forecast for next year? Capricor Therapeutics's earnings are expected to grow from ($0.83) per share to $0.12 per share in the next year. More Earnings Resources from MarketBeat Related Companies: scPharmaceuticals Earnings Results Gossamer Bio Earnings Results Skye Bioscience Earnings Results Greenwich LifeSciences Earnings Results ProQR Therapeutics Earnings Results Regulus Therapeutics Earnings Results CervoMed Earnings Results Seres Therapeutics Earnings Results Omeros Earnings Results Incannex Healthcare Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:CAPR) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capricor Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
